Sea-PAP

CONDITION ADDRESSED: Respiratory distress syndrome

Prevention/Treatment
Prevention/Treatment
  • PREVENTION
  • DIAGNOSTIC
  • TREATMENT
Sea-PAP

CONTACT INFORMATION

Organization

Seattle Children's Hospital & PATH

Individual Contact

Darin Zehrung | Email

Application

  • Low-resource hospital setting

 

Advantages

  • Novel bubbler design; robust preclinical/animal study data
  • Lower work of breathing compared to conventional CPAPs
  • Partnered with PATH 
  • Featured in Xconomy Seattle article

 

Important Milestones Achieved

  • Fully-developed prototype
  • Strong efficacy data collected 

 

Proposed Next Steps in Development

  • Obtaining FDA approval; obtaining CE mark
  • Conducting clinical study (planned for India) 
  • Commercialization expected in 2013

 

Partnerships/Collaboration Network

  • Seattle Children's Hospital
  • Seattle Children's Research Institute
  • PATH  

Stage of Development

Field/clinical studies

Funding Source

Bill & Melinda Gates Foundation. Also, other private foundations.